The Double-Blind Variable Placebo Lead-in Period: Results From Two Antidepressant Clinical Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Double-Blind Variable Placebo Lead-in Period: Results From Two Antidepressant Clinical Trials

Published:2001-12 Issue:6 Volume:21 Page:561-568
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:Journal of Clinical Psychopharmacology

Author:

Faries Douglas E.,Heiligenstein John H.,Tollefson Gary D.,Potter William Z.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference10 articles.

1. Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications?

2. Run-in Periods in Randomized Trials

3. Baseline characteristics of 10-day placebo washout responders in antidepressant trials

4. The introductory placebo washout: A retrospective evaluation

5. Placebo run-in period in studies of depressive disorders

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study;Neuropsychopharmacology;2024-04-22

2. A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligence;Psychiatry Research;2023-09

3. How should we design future mechanistic and/or efficacy clinical trials?;Neuropsychopharmacology;2023-05-26

4. Possible Strategies to Mitigate Placebo or Vehicle Response in Dry Eye Disease Trials: A Narrative Review;Ophthalmology and Therapy;2023-05-20

5. Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo;Translational Psychiatry;2023-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3